Home Tags Neurodegenerative Diseases
Neurodegenerative Diseases Related Content
Researchers at Cambridge University found that over-activity in one brain region links depression, anxiety, and heart disease.
JPND - finding cures for neurodegenerative diseases and working to enable early diagnosis for early targeted treatments with worldwide collaboration.
The October 2020 edition of Open Access Government speaks about global government policy issues, such as health & social care, research & innovation, digital transformation, economic development, international development, environment, energy and equality.
Chairman for the global initiative EU Joint Programme – Neurodegenerative Disease Research (JPND) Professor Philippe Amouyel brings to light their innovative work in neurodegenerative disease research.
A new blood test shows promise in detecting Alzheimer’s as early as 20 years before the onset of cognitive impairment, according to researchers.
Therese Pei Fong Chow Research Centre for Prevention of Dementia, the Chinese University of Hong Kong, discuss if B vitamins can improve cognitive function in older people.
Here, Professor Pamela J. Lein and Professor Anthony S. Wexler of Neurotoxicology discuss the crucial issue of air pollution and brain health.
Shinichi Tokuno from Voice Analysis and Measurement of Pathophysiology, Department of Bioengineering, at the University of Tokyo, shares with us what we need to know about the detection of cognitive impairment with the benefit of voice analysis technology concerning the ageing of people globally.
Learn about these five rare diseases to support governments, scientists and healthcare professionals to find treatments.
An international research team has made a breakthrough in stroke treatment, with a drug that could stop brain swelling without invasive surgery.
Ella Hendrix, Writer, takes it back to basics and explains the difference between Dementia and Alzheimer's disease
Open Access Government delve into the CBD oil revolution in this introduction to CBD which explores the difference between CBD and THC, as well as a range of benefits and safety precautions for cannabidiol use in cancer patients and pregnant women.
The work of the Centers for Disease Control and Prevention, within the U.S. Department of Health & Human Services is examined here, with a special focus on traumatic brain injury.
Cecilia Van Cauwenberghe from Frost & Sullivan’s TechVision Group, provides an overview of Neurodegenerative Diseases.
Cecilia Van Cauwenberghe from Frost & Sullivan’s TechVision Group, examines dementia as a public health issue in Hong Kong.
Here, Professor Timothy Kwok discusses the impact of vitamin B12 on the brain health of older people.
Carolyn R. Klocke and Pamela J. Lein discuss how an individual’s experiences during early life can influence their risk for disease as an adult.
Manchester researchers have contributed towards the discovery of a genetic brain disease which can cause paraplegia and epilepsy in sufferers.
Prof Dr Regina Fluhrer, from the University of Augsburg, explains how intramembrane proteases have been implicated in the emergence of neurodegenerative diseases.
The work of the National Institute on Aging (NIA) is placed into focus here, with examples of how they are supporting vital Alzheimer’s disease research in the U.S and further afield.